11-45811287-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018389.5(SLC35C1):​c.1047G>A​(p.Pro349Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000713 in 1,564,154 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00039 ( 3 hom. )

Consequence

SLC35C1
NM_018389.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.39

Publications

1 publications found
Variant links:
Genes affected
SLC35C1 (HGNC:20197): (solute carrier family 35 member C1) This gene encodes a GDP-fucose transporter that is found in the Golgi apparatus. Mutations in this gene result in congenital disorder of glycosylation type IIc. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
SLC35C1 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 11-45811287-G-A is Benign according to our data. Variant chr11-45811287-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 390906.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.39 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00367 (559/152356) while in subpopulation AFR AF = 0.0127 (530/41590). AF 95% confidence interval is 0.0118. There are 4 homozygotes in GnomAd4. There are 249 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35C1NM_018389.5 linkc.1047G>A p.Pro349Pro synonymous_variant Exon 2 of 2 ENST00000314134.4 NP_060859.4 Q96A29-1B3KQH0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35C1ENST00000314134.4 linkc.1047G>A p.Pro349Pro synonymous_variant Exon 2 of 2 1 NM_018389.5 ENSP00000313318.3 Q96A29-1
SLC35C1ENST00000442528.2 linkc.1008G>A p.Pro336Pro synonymous_variant Exon 3 of 3 1 ENSP00000412408.2 Q96A29-2
SLC35C1ENST00000526817.2 linkc.1008G>A p.Pro336Pro synonymous_variant Exon 3 of 3 2 ENSP00000432145.2 Q96A29-2E9PS26

Frequencies

GnomAD3 genomes
AF:
0.00364
AC:
554
AN:
152238
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000924
AC:
186
AN:
201380
AF XY:
0.000684
show subpopulations
Gnomad AFR exome
AF:
0.0120
Gnomad AMR exome
AF:
0.000413
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000950
Gnomad OTH exome
AF:
0.000207
GnomAD4 exome
AF:
0.000395
AC:
557
AN:
1411798
Hom.:
3
Cov.:
36
AF XY:
0.000375
AC XY:
262
AN XY:
698440
show subpopulations
African (AFR)
AF:
0.0125
AC:
401
AN:
32064
American (AMR)
AF:
0.000407
AC:
16
AN:
39274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23708
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39166
South Asian (SAS)
AF:
0.000161
AC:
13
AN:
80972
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41912
Middle Eastern (MID)
AF:
0.000397
AC:
2
AN:
5040
European-Non Finnish (NFE)
AF:
0.0000596
AC:
65
AN:
1091452
Other (OTH)
AF:
0.00101
AC:
59
AN:
58210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00367
AC:
559
AN:
152356
Hom.:
4
Cov.:
33
AF XY:
0.00334
AC XY:
249
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0127
AC:
530
AN:
41590
American (AMR)
AF:
0.00118
AC:
18
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00195
Hom.:
0
Bravo
AF:
0.00424
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 28, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Leukocyte adhesion deficiency type II Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC35C1: BP4, BP7, BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
4.9
DANN
Benign
0.69
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113735964; hg19: chr11-45832838; COSMIC: COSV106441450; COSMIC: COSV106441450; API